HIV-1-derived lentiviral vectors

Current Topics in Microbiology and Immunology

Volumn 261, Issue , 2002, Pages 31-52

  Ailles, L E ^a   Naldini, L ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; VIRUS PROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL LINE; CENTRAL NERVOUS SYSTEM; GENE THERAPY; HEMATOPOIETIC SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; LYMPHOCYTE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION; REVIEW; RNA TRANSCRIPTION; RNA TRANSPORT; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 0036201470     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-56114-6_2     Document Type: Review

References (109)

1. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
2. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
3. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: Expression and potential for helper virus-free packaging
4. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
5. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein
6. Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF
7. HIV-cell fusion. The viral mousetrap
8. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
9. Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer
10. Interaction of human immunodeficiency virus-derived vectors with wild- type virus in transduced cells
11. Novel design of HIV-based vector system with no viral sequences overlap between packaging and transfer vector constructs
12. HIV-1 nuclear import: In search of a leader
13. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
14. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
15. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titre and efficient gene transfer into mammalian and nonmammalian cells
16. Translational frameshifting at the gag-pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells
17. HIV-1 reverse transcription. A termination step at the center of the genome
18. Lentiviral-mediated gene transfer into human lymphocytes: Role of HIV-1 accessory proteins
19. Immunodeficiency viruses. Spoilt for choice of co-receptors
20. Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation
21. In vivo gene therapy of metachromatic leukodystrophy in lentiviral vectors: Correlation of neuropathology and protection against learning impairments in affected mice
22. Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system
23. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors
24. HIV-1 auxiliary proteins: Making connections in a dying cell
25. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
26. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease
27. Identification of a major co-receptor for primary isolates of HIV-1
28. Expression cloning of new receptors used by simian and human immunodeficiency viruses
29. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription
30. A third-generation lentivirus vector with a conditional packaging system
31. Learning from lentiviruses
32. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology
33. Lentiviruses as gene delivery vectors
34. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
35. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro
36. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
37. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex
38. HIV-1: Fifteen proteins and an RNA
39. HIV-1 infection of non-dividing cells
40. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
41. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import
42. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
43. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors
44. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo
45. Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells
46. - bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors
47. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
48. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor
49. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly
50. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
51. Slower heterosexual spread of HIV-2 than HIV-1
52. The retroviral enzymes
53. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules
54. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type I
55. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells
56. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr
57. Lentiviral gene transfer to the nonhuman primate brain
58. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
59. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
60. 0 lymphocytes
61. Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles?
62. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range
63. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
64. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
65. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
66. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane
67. The multifaceted role of HIV Nef
68. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
69. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin
70. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
71. Development of a self-inactivating lentivirus vector
72. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
73. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
74. Lentiviruses as gene transfer agents for delivery to non-dividing cells
75. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
76. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
77. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export
78. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
79. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver
80. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes
81. Development of HIV vectors for anti-HIV gene therapy
82. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors
83. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex
84. Integration of murine leukemia virus DNA depends on mitosis
85. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation
86. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway
87. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell
88. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
89. HIV nuclear import: What's the flap?
90. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer
91. Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule
92. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
93. Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus type 1
94. Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy
95. HIV-I Vpr interacts with the nuclear transport pathway to promote macrophage infection
96. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly
97. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes
98. Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells
99. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4
100. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
101. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
102. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
103. HIV-1 genome nuclear import is mediated by a central DNA flap
104. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
105. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
106. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
107. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene